Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rong-Ping Guo
Observed name:
Rong-ping Guo
Institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
Observed institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
ORCID:
0000-0002-7530-8902
Observed ORCID:
0000-0002-7530-8902
OpenAlex ID:
A5052196463
LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling
2020
·
Ji Liu
, Rui Xu
, et al.
·
Theranostics
·
41
PDF
Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma
2021
·
Min Deng
, Jia-Bao Lin
, et al.
·
BMC Cancer
·
9
PDF
Efficacy and safety of surufatinib and anti-PD-L1 therapy in combination with hepatic arterial infusion chemotherapy for unresectable intrahepatic cholangiocarcinoma
2026
·
Rong-Ce Zhao
, Xin-Hao Xiong
, et al.
·
World Journal of Gastroenterology
PDF
CRAPT-M: An effective prognostic predictor for hepatocellular carcinoma patients treated with locoregional-bevacizumab-immunotherapy
2026
·
Ze-Hao Zheng
, Rui Xiao
, et al.
·
World Journal of Gastroenterology
HILL: the efficacy and safety of hepatic arterial infusion chemotherapy with the FOLFOX regimen combined with lenvatinib and the PD-L1 inhibitor durvalumab in unresectable hepatocellular carcinoma: a prospective, single-arm, phase 2 clinical trial
2026
·
Shao-Hua Li
, Zhi-Jun Zuo
, et al.
·
Signal Transduction and Targeted Therapy
PDF
Cezanne enhances epithelial mesenchymal transition and prevents anthracycline-induced apoptosis via AKT/mTOR signaling in hepatocellular carcinoma
2021
·
Xiao-Ping Zhong
, Jiahong Wang
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
6
Citation count:
50
H-index:
2
I10-index:
1
Year
Topic
Type